Use of PET scans in Patients with Metastatic Prostate Cancer

What we are studying

This study is being done to see if using a radioactive molecule (FMDHT) is better at detecting the spread of prostate cancer than a usual PET scan.

Who we are studying

• Men
• Races:
  • White
  • African American
  • Asian
  • American Indian or Alaska Native
  • Native Hawaiian or Pacific Islander
  • Other
• All Ethnicities
• Ages 30+

Eligibility Criteria

• Adenocarcinoma of Prostate;clinical staging at time of first FMDHT scan;Metastatic Prostate Cancer;willing to have PSA (Prostate-specific Antigen) evaluated

What is involved

• 1 PET scan
• 1 blood draw

Compensation:

None

Contact Information

Study Coordinator

Megan Brown

Email

mebrown@wakehealth.edu

Phone

336-713-6913